Decision Stands on Generic Drug Price Law

Legislative fallout is occurring in the wake of the U.S. Supreme Court declining to review a lower court decision rejecting Maryland's 2017 law that authorized the state's attorney general to review and regulate price increases of generic or off-patent dr